Study designs and populations
DIVAS trial
Lipidomics analysis was performed in a subset of participants (n = 113 of 195) from the DIVAS trial, a 16-week, single-blind randomized controled parallel trial (registered at www.clinicaltrials.gov under accession number NCT01478958). The DIVAS trial…
[ad_2]
Source link
